Elevance Health, Inc.
DB:A58 주식 보고서
Elevance Health 과거 수익 실적 Elevance Health은 연평균 7.1%의 비율로 수입이 증가해 온 반면, Healthcare 산업은 수입이 증가했으며, 연간 10.6%였습니다. 매출은 연평균 11.2%의 비율로 증가했습니다. Elevance Health의 자기자본이익률은 14.6%이고 순이익률은 3.7%입니다.
주요 정보 Healthcare 산업 성장 15.7% 매출 성장률 11.2% 자기자본 수익률 14.6% 순이익 3.7% 최근 수익 업데이트 30 Sep 2024
최근 과거 실적 업데이트
Third quarter 2024 earnings released: EPS: US$4.36 (vs US$5.48 in 3Q 2023) Oct 17
Elevance Health, Inc. to Report Q3, 2024 Results on Oct 17, 2024 Oct 07
Second quarter 2024 earnings released: EPS: US$9.85 (vs US$7.83 in 2Q 2023) Jul 18
Elevance Health, Inc. to Report Q2, 2024 Results on Jul 17, 2024 Jun 27
First quarter 2024 earnings released: EPS: US$9.59 (vs US$8.38 in 1Q 2023) Apr 18
Elevance Health, Inc. to Report Q1, 2024 Results on Apr 18, 2024 Apr 04
모든 업데이트 표시
Third quarter dividend of US$1.63 announced Oct 20
Elevance Health, Inc. (NYSE:ELV) agreed to acquire CareBridge Medical Group, P.C. Oct 18
Third quarter 2024 earnings released: EPS: US$4.36 (vs US$5.48 in 3Q 2023) Oct 17 Elevance Health, Inc. Declares Dividend for the Fourth Quarter of 2024, Payable on December 20, 2024
Las Mercedes Medical Centers acquired Pasteur and Wellmax Medical Centers from Elevance Health, Inc. (NYSE:ELV). Oct 08
Elevance Health, Inc. to Report Q3, 2024 Results on Oct 17, 2024 Oct 07
Upcoming dividend of US$1.63 per share Sep 03
Clayton, Dubilier & Rice and Elevance Health Announces the Introduction of Mosaic Health, a National Care Delivery Platform Aug 14
Second quarter dividend of US$1.63 announced Jul 19
Second quarter 2024 earnings released: EPS: US$9.85 (vs US$7.83 in 2Q 2023) Jul 18
Elevance Health, Inc. Declares Dividend for the Third Quarter of 2024, Payable on September 25, 2024 Jul 17
Elevance Health, Inc. to Report Q2, 2024 Results on Jul 17, 2024 Jun 27
Upcoming dividend of US$1.63 per share Jun 03
Insider recently sold €6.4m worth of stock Apr 28
First quarter dividend of US$1.63 announced Apr 23 Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024
First quarter 2024 earnings released: EPS: US$9.59 (vs US$8.38 in 1Q 2023) Apr 18
Elevance Health, Inc. to Report Q1, 2024 Results on Apr 18, 2024 Apr 04
StanCorp Financial Group, Inc. completed the acquisition of Life & Disability business of Elevance Health, Inc. Apr 03
StanCorp Financial Group, Inc. completed the acquisition of Life & Disability business of Elevance Health, Inc. Apr 02
Insider recently sold €1.1m worth of stock Mar 13
Upcoming dividend of US$1.63 per share Feb 29
Full year 2023 earnings released: EPS: US$25.38 (vs US$24.56 in FY 2022) Feb 23
Elevance Health, Inc., Annual General Meeting, May 15, 2024 Feb 19
Fourth quarter dividend of US$1.63 announced Jan 29
Elevance Health, Inc. Declares Quarterly Cash Dividend, Payable on March 22, 2024 Jan 26
Full year 2023 earnings released: EPS: US$25.22 (vs US$25.10 in FY 2022) Jan 25
Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024 Jan 24
Elevance Health, Inc. to Report Q4, 2023 Results on Jan 24, 2024 Jan 11
Elevance Health Addresses Healthcare’S Digital Divide by Increasing Access to High-Quality Smartphones and Health-Related Digital Services Jan 10
Upcoming dividend of US$1.48 per share at 1.2% yield Nov 28
Third quarter 2023 earnings released: EPS: US$5.48 (vs US$6.69 in 3Q 2022) Oct 20 Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023
Elevance Health, Inc. to Report Q3, 2023 Results on Oct 18, 2023 Oct 05
Upcoming dividend of US$1.48 per share at 1.3% yield Aug 31 Elevance Health, Inc. Announces Executive Changes Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023
Second quarter 2023 earnings released: EPS: US$7.79 (vs US$6.87 in 2Q 2022) Jul 20
Elevance Health, Inc. to Report Q2, 2023 Results on Jul 19, 2023 Jun 29
Upcoming dividend of US$1.48 per share at 1.3% yield Jun 01
First quarter 2023 earnings released: EPS: US$8.30 (vs US$7.48 in 1Q 2022) Apr 20
Upcoming dividend of US$1.48 per share at 1.3% yield Mar 02
Elevance Health, Inc., Annual General Meeting, May 10, 2023 Feb 18
Elevance Health Inc. (NYSE:ELV) completed the acquisition of BioPlus Specialty Pharmacy Services, LLC from CarepathRx. Feb 16
Full year 2022 earnings released: EPS: US$24.82 (vs US$25.04 in FY 2021) Jan 26 Elevance Health Inc. Provides Earnings Guidance for the Fiscal Year 2023
Elevance Health Inc. (NYSE:ELV) entered into a definitive agreement Louisiana Health Service and Indemnity Company. Jan 24
Elevance Health Inc. to Report Q4, 2022 Results on Jan 25, 2023 Jan 12
Upcoming dividend of US$1.28 per share Nov 25
Insufficient new directors Nov 16
Elevance Health Inc. (NYSE:ELV) entered into an agreement to acquire BioPlus Specialty Pharmacy Services, LLC from CarepathRx. Nov 10
Elevance Health, Inc. Appoints Deanna Strable-Soethout as an Independent Director, Effective November 1, 2022 Oct 26
Third quarter 2022 earnings released: EPS: US$6.68 (vs US$6.20 in 3Q 2021) Oct 21
Elevance Health Inc. Provides Earnings Guidance for Full Year 2022 Oct 20
Elevance Health Inc. to Report Q3, 2022 Results on Oct 19, 2022 Oct 06
Upcoming dividend of US$1.28 per share Sep 01
Second quarter 2022 earnings released: EPS: US$6.79 (vs US$7.33 in 2Q 2021) Jul 21 Elevance Health Inc. Declares Third Quarter 2022 Dividend, Payable on September 23, 2022
Elevance Health Inc. to Report Q2, 2022 Results on Jul 20, 2022 Jul 07
Independent Director recently sold €195k worth of stock Jun 09
Upcoming dividend of US$1.28 per share Jun 02
Anthem, Inc. (NYSE:ANTM) completed the acquisition of Integra MLTC, Inc. from Personal-Touch Home Care, Inc. May 06
Insufficient new directors Apr 27
Anthem, Inc. Provides Earnings Guidance for the Year 2022 Apr 24
First quarter 2022 earnings released: EPS: US$7.39 (vs US$6.80 in 1Q 2021) Apr 21
Anthem, Inc. Declares Second Quarter 2022 Dividend, Payable on June 24, 2022 Apr 21
Anthem, Inc. to Report Q1, 2022 Results on Apr 20, 2022 Apr 07
Senior VP recently sold €363k worth of stock Mar 12
Upcoming dividend of US$1.28 per share Mar 02
Anthem, Inc., Annual General Meeting, May 18, 2022 Feb 19
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Jan 28
Anthem, Inc. Provides Earnings Guidance for the Full Year of 2022 Jan 27
Upcoming dividend of US$1.13 per share Nov 25
Senior VP recently sold €429k worth of stock Oct 31
Third quarter 2021 earnings released: EPS US$6.20 (vs US$0.88 in 3Q 2020) Oct 22
Upcoming dividend of US$1.13 per share Sep 02
Insider recently bought €425k worth of stock Jul 28
Second quarter 2021 earnings released: EPS US$7.33 (vs US$9.03 in 2Q 2020) Jul 23
Anthem, Inc. Provides Earnings Guidance for the Year 2021 Jul 23 Anthem, Inc.(NYSE:ANTM) dropped from Russell 3000 Growth Index
Upcoming dividend of US$1.13 per share Jun 02
Independent Director recently sold €422k worth of stock May 26
Inspire Medical Systems, Inc. Announces Positive Coverage Policy Issued by Anthem for Inspire Therapy May 21
Anthem, Inc. Enables Secure Exchange of Health Information to Enhance Healthcare Experience May 20
First quarter 2021 earnings released: EPS US$6.80 (vs US$6.03 in 1Q 2020) Apr 24
Anthem, Inc. Provides Financial Guidance for Fiscal 2021 Apr 24
New 90-day high: €277 Mar 09
Senior VP recently sold €580k worth of stock Mar 09
Indiana Fever and Anthem, Inc. Team Up for Multi-Year Partnership Focused on Sports, Leadership, and Social Justice Feb 24
Elevance Health 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역 DB:A58 수익, 비용 및 수입 (USD Millions ) 날짜 수익 수익 G+A 비용 R&D 비용 30 Sep 24 174,015 6,418 37,383 0 30 Jun 24 171,719 6,691 37,407 0 31 Mar 24 171,745 6,244 36,666 0 31 Dec 23 171,340 5,987 36,236 0 30 Sep 23 168,626 5,996 35,718 0 30 Jun 23 165,716 6,310 33,553 0 31 Mar 23 160,676 6,094 31,749 0 31 Dec 22 156,599 5,894 30,696 0 30 Sep 22 153,251 6,166 29,605 0 30 Jun 22 149,134 6,072 28,496 0 31 Mar 22 144,353 6,228 27,590 0 31 Dec 21 138,643 6,158 26,604 0 30 Sep 21 133,883 5,518 26,357 0 30 Jun 21 129,219 4,231 25,839 0 31 Mar 21 124,632 4,714 25,675 0 31 Dec 20 121,868 4,572 25,202 0 30 Sep 20 117,449 4,955 23,013 0 30 Jun 20 112,965 5,916 20,850 0 31 Mar 20 109,167 4,779 17,955 0 31 Dec 19 104,212 4,807 15,356 0 30 Sep 19 100,165 4,298 14,323 0 30 Jun 19 96,742 4,074 13,706 0 31 Mar 19 94,220 3,989 13,758 0 31 Dec 18 92,091 3,750 14,020 0 30 Sep 18 91,409 4,556 13,681 0 30 Jun 18 90,584 4,344 13,146 0 31 Mar 18 90,061 4,145 12,772 0 31 Dec 17 90,049 3,843 12,650 0 30 Sep 17 89,055 2,980 12,520 0 30 Jun 17 88,038 2,851 12,634 0 31 Mar 17 87,083 2,777 12,549 0 31 Dec 16 84,862 2,470 12,559 0 30 Sep 16 83,364 2,282 12,562 0 30 Jun 16 81,866 2,319 12,518 0 31 Mar 16 80,412 2,398 12,590 0 31 Dec 15 79,158 2,560 12,535 0 30 Sep 15 77,959 2,886 12,299 0 30 Jun 15 76,605 2,862 12,187 0 31 Mar 15 75,066 2,734 12,032 0 31 Dec 14 73,886 2,560 11,748 0 30 Sep 14 72,792 2,362 11,361 0 30 Jun 14 72,090 2,385 10,936 0 31 Mar 14 71,307 2,453 10,485 0 31 Dec 13 71,024 2,634 9,953 0
양질의 수익: A58 은 높은 수익 을 보유하고 있습니다.
이익 마진 증가: A58 의 현재 순이익 이익률 (3.7%) 작년보다 높습니다 (3.6%).
과거 수익 성장 분석
수익추이: A58 의 수입은 지난 5년 동안 매년 7.1% 씩 증가했습니다.
성장 가속화: 지난 1년간 A58 의 수익 증가율( 7% )은 5년 평균( 7.1% 보다 낮습니다. 년도).
수익 대 산업: 지난 1년간 A58 수익 성장( 7% )은 Healthcare 업계 40.5% 능가하지 못했습니다. 40.5%.
자기자본 수익률
높은 ROE: A58 의 자본 수익률 ( 14.6% )은 낮음 으로 간주됩니다.
Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}